Latest News and Press Releases

Hafrun Fridriksdottir, previously Executive VP and Head of Global R&D at Teva, will become Chief Operating Officer Mark Levick has decided to step down as Chief Executive Officer and Robert...

Hafrun Fridriksdottir, previously Executive VP and Head of Global R&D at Teva, will become Chief Operating Officer Mark Levick has decided to step down as Chief Executive Officer and Robert...

Hafrún Friðriksdóttir, sem áður var framkvæmdastjóri alþjóðlegra rannsókna og þróunar fyrir lyfjafyrirtækið Teva, tekur við sem framkvæmdastjóri rekstrarMark Levick, forstjóri hefur ákveðið að biðjast...

Alvotech S.A. (“Alvotech”) has submitted its application to Nasdaq Iceland for admission of its shares for trading on the Nasdaq Iceland Main Market under the ticker symbol “ALVO”. The application...

Alvotech S.A. (“Alvotech”) hefur lagt inn umsókn til Nasdaq Iceland um töku hlutabréfa fyrirtækisins til viðskipta á Aðalmarkaði Nasdaq Iceland undir auðkenninu „ALVO“. Umsóknin bíður nú samþykkis...

Existing senior bonds upsized by $70 million with additional investment from a consortium of institutional investorsAlvotech acquires the Reykjavik manufacturing facility, previously utilized...

Flokkur veðskuldabréfa stækkaður um 10,2 milljarða króna með aðkomu hóps nýrra stofnanafjárfestaAlvotech eignast verksmiðjubygginguna í Vatnsmýri, sem áður var leigð, og fær viðbótarfjármögnun að...

Existing senior bonds upsized by $70 million with additional investment from a consortium of institutional investorsAlvotech acquires the Reykjavik manufacturing facility, previously utilized under a...

Revenue for first nine months of 2022 increased to $59.2 million, compared to $2.0 million for the same period in 2021 Discussions with U.S. FDA progressed regarding both biologic license...

Revenue for first nine months of 2022 increased to $59.2 million, compared to $2.0 million for the same period in 2021Discussions with U.S. FDA progressed regarding both biologic license applications...